These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 17727931

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
    Havrilesky LJ, Leath CA, Huh W, Calingaert B, Bentley RC, Soper JT, Alvarez Secord A.
    Gynecol Oncol; 2004 May; 93(2):429-34. PubMed ID: 15099957
    [Abstract] [Full Text] [Related]

  • 4. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [Abstract] [Full Text] [Related]

  • 5. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT.
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. New developments in the surgical therapy of cervical carcinoma.
    Dornhöfer N, Höckel M.
    Ann N Y Acad Sci; 2008 Sep; 1138():233-52. PubMed ID: 18837903
    [Abstract] [Full Text] [Related]

  • 8. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y, Gorchev G.
    J BUON; 2007 Sep; 12(1):57-63. PubMed ID: 17436403
    [Abstract] [Full Text] [Related]

  • 9. Matched-case comparison for the efficacy of neoadjuvant chemotherapy before surgery in FIGO stage IB1-IIA cervical cancer.
    Kim HS, Kim JY, Park NH, Kim K, Chung HH, Kim YB, Kim JW, Kim HJ, Song YS, Kang SB.
    Gynecol Oncol; 2010 Nov; 119(2):217-24. PubMed ID: 20705335
    [Abstract] [Full Text] [Related]

  • 10. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M, Hentschel B, Horn LC.
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [Abstract] [Full Text] [Related]

  • 11. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA, Covens A, Franssen E, Chapman W, Shaw P, Colgan T, Murphy J, DePetrillo D, Lickrish G, Laframboise S, Rosen B.
    Cancer; 2003 Apr 15; 97(8):1904-8. PubMed ID: 12673716
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.
    Yessaian A, Magistris A, Burger RA, Monk BJ.
    Gynecol Oncol; 2004 Jul 15; 94(1):61-6. PubMed ID: 15262120
    [Abstract] [Full Text] [Related]

  • 14. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
    Chen Y, Xu H, Li Y, Wang D, Li J, Yuan J, Liang Z.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2847-55. PubMed ID: 18649105
    [Abstract] [Full Text] [Related]

  • 15. Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial.
    Lahousen M, Haas J, Pickel H, Hackl A, Kurz C, Ogris H, Stummvoll W, Winter R.
    Gynecol Oncol; 1999 May 15; 73(2):196-201. PubMed ID: 10329034
    [Abstract] [Full Text] [Related]

  • 16. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in patients with Ib1 stage cervical cancer: analysis of surgical and oncological outcome.
    Pellegrino A, Vizza E, Fruscio R, Villa A, Corrado G, Villa M, Dell'Anna T, Vitobello D.
    Eur J Surg Oncol; 2009 Jan 15; 35(1):98-103. PubMed ID: 18760562
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N, Umayahara K, Fujiwara K, Hirai Y, Takizawa K, Hasumi K.
    Gynecol Oncol; 2006 Nov 15; 103(2):618-22. PubMed ID: 16777200
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.